Abstract
The high resolution structure of the new therapeutic target, cathepsin K, complexed with the potent mechanism-based inhibitor, APC3328, reveals the substrate-binding sites of this cysteine proteinase and validates the binding mode for this inhibitor class.
| Original language | English |
|---|---|
| Pages (from-to) | 105-109 |
| Number of pages | 5 |
| Journal | Nature Structural Biology |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1997 |
| Externally published | Yes |